Disciplined Investors L.L.C. Acquires New Holdings in The Cigna Group (NYSE:CI)

Disciplined Investors L.L.C. bought a new stake in shares of The Cigna Group (NYSE:CI - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 929 shares of the health services provider's stock, valued at approximately $262,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Norges Bank acquired a new position in shares of The Cigna Group during the fourth quarter valued at $867,785,000. Raymond James Financial Inc. bought a new position in The Cigna Group in the 4th quarter valued at about $313,911,000. GQG Partners LLC increased its stake in The Cigna Group by 22.4% during the 4th quarter. GQG Partners LLC now owns 4,021,582 shares of the health services provider's stock valued at $1,110,520,000 after buying an additional 737,099 shares during the period. Massachusetts Financial Services Co. MA raised its position in shares of The Cigna Group by 4.5% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,556,278 shares of the health services provider's stock worth $3,191,151,000 after buying an additional 501,320 shares in the last quarter. Finally, Amundi lifted its stake in shares of The Cigna Group by 19.9% in the 4th quarter. Amundi now owns 2,254,050 shares of the health services provider's stock worth $628,579,000 after acquiring an additional 374,865 shares during the period. Institutional investors own 86.99% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently commented on CI. Oppenheimer lowered their price objective on shares of The Cigna Group from $400.00 to $375.00 and set an "outperform" rating on the stock in a research note on Friday, January 31st. Wells Fargo & Company lowered their price target on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a research report on Tuesday, February 4th. Barclays cut their price objective on The Cigna Group from $420.00 to $339.00 and set an "overweight" rating for the company in a report on Friday, January 31st. Morgan Stanley decreased their target price on The Cigna Group from $403.00 to $379.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Finally, Raymond James reiterated a "strong-buy" rating and issued a $360.00 price target (down from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat, The Cigna Group currently has an average rating of "Buy" and a consensus price target of $373.25.

Remove Ads

Insider Activity

In other news, Director Elder Granger sold 2,376 shares of The Cigna Group stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $310.35, for a total transaction of $737,391.60. Following the completion of the sale, the director now directly owns 5,471 shares in the company, valued at $1,697,924.85. The trade was a 30.28 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO David Cordani sold 26,527 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the transaction, the chief executive officer now owns 127,767 shares in the company, valued at $39,367,568.04. This represents a 17.19 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,751 shares of company stock worth $13,603,991 in the last ninety days. Corporate insiders own 0.70% of the company's stock.

The Cigna Group Stock Down 1.8 %

NYSE:CI traded down $5.67 during trading hours on Monday, hitting $316.73. 1,746,500 shares of the stock traded hands, compared to its average volume of 1,670,075. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The firm has a market cap of $86.68 billion, a price-to-earnings ratio of 25.96, a PEG ratio of 0.98 and a beta of 0.51. The firm has a 50 day moving average price of $308.72 and a 200 day moving average price of $312.39.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the previous year, the company earned $6.79 earnings per share. Equities research analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th were paid a dividend of $1.51 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.91%. This is a positive change from The Cigna Group's previous quarterly dividend of $1.40. The Cigna Group's dividend payout ratio (DPR) is 49.35%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.